Selected research
Market Outlook & Growth Opportunities
Global Plasmid DNA Production & Manufacturing Service Market Outlook and Growth Opportunities 2026
Market perspective
The global Plasmid DNA Production & Manufacturing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Plasmid DNA Production & Manufacturing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Plasmid DNA Production & Manufacturing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Plasmid DNA Production & Manufacturing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Plasmid DNA Production & Manufacturing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Plasmid DNA Production & Manufacturing Service market include Charles River Laboratories, VGXI, Inc., Danaher (Aldevron), Kaneka Corp., Nature Technology, Cell and Gene Therapy Catapult, Eurofins Genomics, Lonza and Luminous BioSciences, LLC, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Plasmid DNA Production & Manufacturing Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Plasmid DNA Production & Manufacturing Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Plasmid DNA Production & Manufacturing Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Plasmid DNA Production & Manufacturing Service market.
Plasmid DNA Production & Manufacturing Service Segment by Company
Charles River Laboratories
VGXI, Inc.
Danaher (Aldevron)
Kaneka Corp.
Nature Technology
Cell and Gene Therapy Catapult
Eurofins Genomics
Lonza
Luminous BioSciences, LLC
Akron Biotech
Plasmid DNA Production & Manufacturing Service Segment by Type
R&D Grade
GMP Grade
Plasmid DNA Production & Manufacturing Service Segment by Application
DNA Vaccines
Cell & Gene Therapy
Immunotherapy
Others
Plasmid DNA Production & Manufacturing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Plasmid DNA Production & Manufacturing Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Plasmid DNA Production & Manufacturing Service key companies, revenue, market share, and recent developments.
3. To split the Plasmid DNA Production & Manufacturing Service breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Plasmid DNA Production & Manufacturing Service market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Plasmid DNA Production & Manufacturing Service significant trends, drivers, influence factors in global and regions.
6. To analyze Plasmid DNA Production & Manufacturing Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasmid DNA Production & Manufacturing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Plasmid DNA Production & Manufacturing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasmid DNA Production & Manufacturing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Plasmid DNA Production & Manufacturing Service industry.
Chapter 3: Detailed analysis of Plasmid DNA Production & Manufacturing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Plasmid DNA Production & Manufacturing Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Plasmid DNA Production & Manufacturing Service in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- R&D Grade
- GMP Grade
Applications
- DNA Vaccines
- Cell & Gene Therapy
- Immunotherapy
- Others
Companies covered
- Charles River Laboratories
- VGXI, Inc.
- Danaher (Aldevron)
- Kaneka Corp.
- Nature Technology
- Cell and Gene Therapy Catapult
- Eurofins Genomics
- Lonza
- Luminous BioSciences, LLC
- Akron Biotech
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Plasmid DNA Production & Manufacturing Service Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Plasmid DNA Production & Manufacturing Service Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Plasmid DNA Production & Manufacturing Service Market Dynamics
- 2.1 Plasmid DNA Production & Manufacturing Service Industry Trends
- 2.2 Plasmid DNA Production & Manufacturing Service Industry Drivers
- 2.3 Plasmid DNA Production & Manufacturing Service Industry Opportunities and Challenges
- 2.4 Plasmid DNA Production & Manufacturing Service Industry Restraints
3 Plasmid DNA Production & Manufacturing Service Market by Company
- 3.1 Global Plasmid DNA Production & Manufacturing Service Company Revenue Ranking in 2025
- 3.2 Global Plasmid DNA Production & Manufacturing Service Revenue by Company (2021-2026)
- 3.3 Global Plasmid DNA Production & Manufacturing Service Company Ranking (2024-2026)
- 3.4 Global Plasmid DNA Production & Manufacturing Service Company Manufacturing Base and Headquarters
- 3.5 Global Plasmid DNA Production & Manufacturing Service Company Product Type and Application
- 3.6 Global Plasmid DNA Production & Manufacturing Service Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Plasmid DNA Production & Manufacturing Service Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Plasmid DNA Production & Manufacturing Service Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Plasmid DNA Production & Manufacturing Service Market by Type
- 4.1 Plasmid DNA Production & Manufacturing Service Type Introduction
- 4.1.1 R&D Grade
- 4.1.2 GMP Grade
- 4.2 Global Plasmid DNA Production & Manufacturing Service Sales Value by Type
- 4.2.1 Global Plasmid DNA Production & Manufacturing Service Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Plasmid DNA Production & Manufacturing Service Sales Value by Type (2021-2032)
- 4.2.3 Global Plasmid DNA Production & Manufacturing Service Sales Value Share by Type (2021-2032)
5 Plasmid DNA Production & Manufacturing Service Market by Application
- 5.1 Plasmid DNA Production & Manufacturing Service Application Introduction
- 5.1.1 DNA Vaccines
- 5.1.2 Cell & Gene Therapy
- 5.1.3 Immunotherapy
- 5.1.4 Others
- 5.2 Global Plasmid DNA Production & Manufacturing Service Sales Value by Application
- 5.2.1 Global Plasmid DNA Production & Manufacturing Service Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Plasmid DNA Production & Manufacturing Service Sales Value by Application (2021-2032)
- 5.2.3 Global Plasmid DNA Production & Manufacturing Service Sales Value Share by Application (2021-2032)
6 Plasmid DNA Production & Manufacturing Service Regional Value Analysis
- 6.1 Global Plasmid DNA Production & Manufacturing Service Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Plasmid DNA Production & Manufacturing Service Sales Value by Region (2021-2032)
- 6.2.1 Global Plasmid DNA Production & Manufacturing Service Sales Value by Region: 2021-2026
- 6.2.2 Global Plasmid DNA Production & Manufacturing Service Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Plasmid DNA Production & Manufacturing Service Sales Value (2021-2032)
- 6.3.2 North America Plasmid DNA Production & Manufacturing Service Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Plasmid DNA Production & Manufacturing Service Sales Value (2021-2032)
- 6.4.2 Europe Plasmid DNA Production & Manufacturing Service Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Plasmid DNA Production & Manufacturing Service Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Plasmid DNA Production & Manufacturing Service Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Plasmid DNA Production & Manufacturing Service Sales Value (2021-2032)
- 6.6.2 South America Plasmid DNA Production & Manufacturing Service Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Plasmid DNA Production & Manufacturing Service Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Plasmid DNA Production & Manufacturing Service Sales Value Share by Country, 2025 VS 2032
7 Plasmid DNA Production & Manufacturing Service Country-level Value Analysis
- 7.1 Global Plasmid DNA Production & Manufacturing Service Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Plasmid DNA Production & Manufacturing Service Sales Value by Country (2021-2032)
- 7.2.1 Global Plasmid DNA Production & Manufacturing Service Sales Value by Country (2021-2026)
- 7.2.2 Global Plasmid DNA Production & Manufacturing Service Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Plasmid DNA Production & Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Plasmid DNA Production & Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Plasmid DNA Production & Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Plasmid DNA Production & Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Plasmid DNA Production & Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Plasmid DNA Production & Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Plasmid DNA Production & Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Plasmid DNA Production & Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Plasmid DNA Production & Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Plasmid DNA Production & Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Plasmid DNA Production & Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Plasmid DNA Production & Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Plasmid DNA Production & Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.7.2 France Plasmid DNA Production & Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Plasmid DNA Production & Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Plasmid DNA Production & Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Plasmid DNA Production & Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Plasmid DNA Production & Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Plasmid DNA Production & Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Plasmid DNA Production & Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Plasmid DNA Production & Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Plasmid DNA Production & Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Plasmid DNA Production & Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Plasmid DNA Production & Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Plasmid DNA Production & Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Plasmid DNA Production & Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Plasmid DNA Production & Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Plasmid DNA Production & Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Plasmid DNA Production & Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Plasmid DNA Production & Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Plasmid DNA Production & Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Plasmid DNA Production & Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Plasmid DNA Production & Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Plasmid DNA Production & Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.14.2 China Plasmid DNA Production & Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Plasmid DNA Production & Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Plasmid DNA Production & Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Plasmid DNA Production & Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Plasmid DNA Production & Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Plasmid DNA Production & Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Plasmid DNA Production & Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Plasmid DNA Production & Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Plasmid DNA Production & Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.17.2 India Plasmid DNA Production & Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Plasmid DNA Production & Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Plasmid DNA Production & Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Plasmid DNA Production & Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Plasmid DNA Production & Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Plasmid DNA Production & Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Plasmid DNA Production & Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Plasmid DNA Production & Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Plasmid DNA Production & Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Plasmid DNA Production & Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Plasmid DNA Production & Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Plasmid DNA Production & Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Plasmid DNA Production & Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Plasmid DNA Production & Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Plasmid DNA Production & Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Plasmid DNA Production & Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Plasmid DNA Production & Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Plasmid DNA Production & Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Plasmid DNA Production & Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Plasmid DNA Production & Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Plasmid DNA Production & Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Plasmid DNA Production & Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Plasmid DNA Production & Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Plasmid DNA Production & Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Plasmid DNA Production & Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Plasmid DNA Production & Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Plasmid DNA Production & Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Plasmid DNA Production & Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Plasmid DNA Production & Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Plasmid DNA Production & Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Plasmid DNA Production & Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Plasmid DNA Production & Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Plasmid DNA Production & Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Plasmid DNA Production & Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Plasmid DNA Production & Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Plasmid DNA Production & Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Plasmid DNA Production & Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Plasmid DNA Production & Manufacturing Service Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Plasmid DNA Production & Manufacturing Service Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Plasmid DNA Production & Manufacturing Service Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Plasmid DNA Production & Manufacturing Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Charles River Laboratories
- 8.1.1 Charles River Laboratories Company Information
- 8.1.2 Charles River Laboratories Business Overview
- 8.1.3 Charles River Laboratories Plasmid DNA Production & Manufacturing Service Revenue and Gross Margin (2021-2026)
- 8.1.4 Charles River Laboratories Plasmid DNA Production & Manufacturing Service Product Portfolio
- 8.1.5 Charles River Laboratories Recent Developments
- 8.2 VGXI, Inc.
- 8.2.1 VGXI, Inc. Company Information
- 8.2.2 VGXI, Inc. Business Overview
- 8.2.3 VGXI, Inc. Plasmid DNA Production & Manufacturing Service Revenue and Gross Margin (2021-2026)
- 8.2.4 VGXI, Inc. Plasmid DNA Production & Manufacturing Service Product Portfolio
- 8.2.5 VGXI, Inc. Recent Developments
- 8.3 Danaher (Aldevron)
- 8.3.1 Danaher (Aldevron) Company Information
- 8.3.2 Danaher (Aldevron) Business Overview
- 8.3.3 Danaher (Aldevron) Plasmid DNA Production & Manufacturing Service Revenue and Gross Margin (2021-2026)
- 8.3.4 Danaher (Aldevron) Plasmid DNA Production & Manufacturing Service Product Portfolio
- 8.3.5 Danaher (Aldevron) Recent Developments
- 8.4 Kaneka Corp.
- 8.4.1 Kaneka Corp. Company Information
- 8.4.2 Kaneka Corp. Business Overview
- 8.4.3 Kaneka Corp. Plasmid DNA Production & Manufacturing Service Revenue and Gross Margin (2021-2026)
- 8.4.4 Kaneka Corp. Plasmid DNA Production & Manufacturing Service Product Portfolio
- 8.4.5 Kaneka Corp. Recent Developments
- 8.5 Nature Technology
- 8.5.1 Nature Technology Company Information
- 8.5.2 Nature Technology Business Overview
- 8.5.3 Nature Technology Plasmid DNA Production & Manufacturing Service Revenue and Gross Margin (2021-2026)
- 8.5.4 Nature Technology Plasmid DNA Production & Manufacturing Service Product Portfolio
- 8.5.5 Nature Technology Recent Developments
- 8.6 Cell and Gene Therapy Catapult
- 8.6.1 Cell and Gene Therapy Catapult Company Information
- 8.6.2 Cell and Gene Therapy Catapult Business Overview
- 8.6.3 Cell and Gene Therapy Catapult Plasmid DNA Production & Manufacturing Service Revenue and Gross Margin (2021-2026)
- 8.6.4 Cell and Gene Therapy Catapult Plasmid DNA Production & Manufacturing Service Product Portfolio
- 8.6.5 Cell and Gene Therapy Catapult Recent Developments
- 8.7 Eurofins Genomics
- 8.7.1 Eurofins Genomics Company Information
- 8.7.2 Eurofins Genomics Business Overview
- 8.7.3 Eurofins Genomics Plasmid DNA Production & Manufacturing Service Revenue and Gross Margin (2021-2026)
- 8.7.4 Eurofins Genomics Plasmid DNA Production & Manufacturing Service Product Portfolio
- 8.7.5 Eurofins Genomics Recent Developments
- 8.8 Lonza
- 8.8.1 Lonza Company Information
- 8.8.2 Lonza Business Overview
- 8.8.3 Lonza Plasmid DNA Production & Manufacturing Service Revenue and Gross Margin (2021-2026)
- 8.8.4 Lonza Plasmid DNA Production & Manufacturing Service Product Portfolio
- 8.8.5 Lonza Recent Developments
- 8.9 Luminous BioSciences, LLC
- 8.9.1 Luminous BioSciences, LLC Company Information
- 8.9.2 Luminous BioSciences, LLC Business Overview
- 8.9.3 Luminous BioSciences, LLC Plasmid DNA Production & Manufacturing Service Revenue and Gross Margin (2021-2026)
- 8.9.4 Luminous BioSciences, LLC Plasmid DNA Production & Manufacturing Service Product Portfolio
- 8.9.5 Luminous BioSciences, LLC Recent Developments
- 8.10 Akron Biotech
- 8.10.1 Akron Biotech Company Information
- 8.10.2 Akron Biotech Business Overview
- 8.10.3 Akron Biotech Plasmid DNA Production & Manufacturing Service Revenue and Gross Margin (2021-2026)
- 8.10.4 Akron Biotech Plasmid DNA Production & Manufacturing Service Product Portfolio
- 8.10.5 Akron Biotech Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst